Disease Overview：Peripheral Artery Disease（PAD）
Peripheral Artery Disease (PAD) is a chronic circulatory condition characterized by narrowing or blockage of the peripheral arteries—most commonly in the lower extremities—due to atherosclerotic plaque buildup. This results in reduced blood flow, manifesting as intermittent claudication, rest pain, non-healing ulcers, or critical limb ischemia. Left untreated, PAD significantly increases the risk of myocardial infarction, stroke, and limb amputation. Diagnosis relies on clinical assessment, ankle-brachial index (ABI), duplex ultrasonography, CT angiography, or digital subtraction angiography (DSA). Management spans lifestyle modification, pharmacotherapy (antiplatelets, statins, antihypertensives), supervised exercise, and revascularization—either endovascular (angioplasty, stenting, atherectomy) or surgical (bypass grafting)—tailored to lesion morphology and patient comorbidities.
China offers distinct advantages for PAD treatment: its cardiovascular centers—many accredited by international bodies such as JCI—employ world-class interventional cardiologists and vascular surgeons with extensive experience in complex infrainguinal and multilevel disease. Advanced imaging (e.g., 3D rotational angiography, intravascular ultrasound) and next-generation devices—including drug-coated balloons and bioresorbable scaffolds—are routinely deployed. Clinical outcomes align with global benchmarks: multi-center studies report >90% technical success in endovascular interventions and limb salvage rates exceeding 85% at one year for critical limb ischemia. Crucially, costs are typically 40–60% lower than in the US or Western Europe without compromising quality—enabling access to high-value care.
As a dedicated medical tourism agency, we facilitate seamless international patient journeys: coordinating appointments at top-tier hospitals, providing itemized, transparent pricing in advance, arranging visa support, medical translation, accommodation, and post-procedure follow-up—all under one coordinated service.
Peripheral Artery Disease: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Peripheral Artery Disease (PAD)
Non-Surgical / Conservative Management
*Target criteria:* Claudication without rest pain, ABI ≥0.4, no tissue loss, stable comorbidities (e.g., controlled hypertension, diabetes).
- •Lifestyle & Supervised Exercise Therapy
- Smoking cessation counseling + pharmacotherapy (varenicline 12-week course): $65–$95
- •Pharmacotherapy (3-month starter regimen)
- High-intensity statin (atorvastatin 40–80 mg/day): $12–$20 - Antihypertensive (amlodipine or ACEi, generic): $8–$15 - Cilostazol (100 mg BID, if no heart failure): $110–$165
- •Diagnostic Monitoring (per episode)
- Fasting lipid panel + HbA1c + renal function (Cr, eGFR): $35–$50 - Duplex ultrasound (full lower limb mapping): $120–$180
Surgical / Interventional Procedures
*Eligibility:* Rest pain, non-healing ulcer (Rutherford Class 4–5), critical limb ischemia (CLI), failed conservative therapy, anatomically suitable lesions.
- •Endovascular Revascularization
- Drug-coated balloon (DCB) angioplasty (≥2 lesions or in-stent restenosis): $3,800–$5,600 - Bare-metal stent (femoropopliteal): $2,900–$4,300 - Nitinol self-expanding stent (below-knee): $4,500–$6,700
- •Open Surgical Bypass
- Femoral-tibial bypass (vein graft, complex CLI): $7,800–$11,200
- •Preoperative Workup (mandatory for all procedures)
- Cardiac stress test (if CAD suspected) + ECG + echocardiogram: $320–$480 - Coagulation panel + crossmatch + infection screen: $95–$140
Special/Complex Condition Management
- •Chronic Limb-Threatening Ischemia (CLTI) with Diabetes & Renal Failure
- Wound care coordination (multidisciplinary clinic, 4-week intensive): $1,100–$1,700
- •In-Stent Restenosis or Graft Failure
Quick Selection Guide
- •Age <65, mild claudication, budget <$500: Start with supervised exercise + dual antiplatelet/statin ($350–$500 total)
- •Age 65–80, Rutherford Class 3–4, moderate budget ($3,000–$6,000): DCB angioplasty ($3,800–$5,600) — optimal balance of efficacy and durability
- •Age >80, CLI + diabetes + renal impairment, urgent limb salvage: Vein bypass ($7,800–$11,200) — superior long-term patency vs. stents in below-knee disease
- •Severe comorbidities (NYHA III–IV HF, eGFR <30): Palliative medical management only — avoid invasive procedures; focus on pain control and wound prevention ($200–$400/month)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Peripheral Artery Disease Medical Vacation Packages
Curated transparent all-inclusive packages combining Peripheral Artery Disease treatment with China top medical destinations:
